Location History:
- Saltsjobaden, SE (2011)
- Solna, SE (2011)
Company Filing History:
Years Active: 2011
Title: The Innovations of Robert Engovist
Introduction
Robert Engovist is a notable inventor based in Saltsjöbaden, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for treating autoimmune diseases. With a total of 2 patents, Engovist's work exemplifies the intersection of innovation and healthcare.
Latest Patents
Engovist's latest patents include "Alkyl substituted indoloquinoxalines" and "Compounds and use thereof." The first patent focuses on novel substituted indoloquinoxalines that are useful as drugs for preventing and/or treating autoimmune diseases. The compounds are characterized by specific formulas where various groups are selected to enhance their pharmaceutical efficacy. The second patent outlines a method of preparing these compounds, their use as pharmaceuticals, and methods of treatment.
Career Highlights
Throughout his career, Engovist has worked with several companies, including Oxypharma AB and Vironova AB. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug development.
Collaborations
Engovist has collaborated with notable colleagues such as Jan Bergman and Bengt Gerdin. These partnerships have fostered a creative environment that has led to significant breakthroughs in his field.
Conclusion
Robert Engovist's contributions to pharmaceutical innovation highlight the importance of research and collaboration in developing new treatments for autoimmune diseases. His patents reflect a commitment to improving healthcare through scientific advancement.